BRUCE W. BOOTH, MD

Plain English
This study focused on creating training resources to help stroke researchers and individuals who have experienced a stroke work together more effectively on research projects. After participating in two new training modules, researchers reported a significant increase in their likelihood of involving stroke survivors in their research efforts. This matters because improving collaboration can lead to more relevant and impactful research outcomes. Who this helps: This benefits both stroke researchers and stroke survivors by enhancing their teamwork in research initiatives.

Plain English
This study investigates a digital health program called "Love Your Brain," designed to help prevent strokes by encouraging people to visit their doctors for cardiovascular check-ups and improving their knowledge and behaviors related to stroke prevention. Researchers aim to enroll 894 participants and compare the effects of two digital approaches—an online course and text messages—against a standard control group. They expect that by the end of the study, the program will show at least a 30% improvement in participants visiting their doctors and adopting healthier habits. Who this helps: This benefits patients at risk for stroke and healthcare providers looking for effective prevention strategies.

Plain English
The study focused on a new drug called olutasidenib, which has been approved by the FDA for treating adults with a specific type of leukemia called acute myeloid leukemia, particularly those with a certain genetic mutation. In a clinical trial involving 147 patients, 35% achieved complete or partial remission after treatment, with a median response time of nearly 26 months. Additionally, 34% of patients who needed blood transfusions were able to stop needing them after taking the drug. Who this helps: This benefits adult patients with relapsed or refractory acute myeloid leukemia with the specific genetic mutation.

Plain English
This study looked at how biases in machine learning models can unfairly affect hiring processes, like evaluating resumes and interviews. The researchers developed a four-step guide for creating these models, which includes generating data, training the model, testing it, and using it in hiring. They found that bias can creep in at every stage, but they also identified ways to reduce bias that are both effective and comply with legal standards, emphasizing the need for more collaboration in this field. Who this helps: This benefits employers and job seekers by promoting fairer hiring practices.

Plain English
This study focused on the use of abatacept, a new drug, to prevent acute graft-versus-host disease (aGVHD) in patients undergoing stem cell transplants. The findings showed that patients taking abatacept had a 67% lower risk of developing severe aGVHD and a 68% higher chance of surviving without aGVHD at 180 days compared to those who received a placebo. In another part of the study, patients using abatacept along with other medications had a 98% survival rate, significantly higher than the 75% survival rate in those who received standard treatment without abatacept. Who this helps: This benefits patients undergoing stem cell transplants from unrelated donors, especially children and adults at risk for aGVHD.

Plain English
This study looked at how to better determine the right dosages for cancer treatments, especially when combining different drugs or using them for new purposes. Researchers found that drug responses can vary significantly depending on factors like the type of cancer and the specific group of patients being treated. Understanding these differences is important for ensuring patients receive the most effective and safe doses of their medications. Who this helps: This benefits cancer patients and their doctors by improving treatment effectiveness.

Plain English
The study explored a digital health program called "Love Your Brain" to help prevent strokes in Australia. It involved 894 participants aged 45 and older, who were divided into three groups: one received an online course, another got motivational text messages, and the last received standard information about stroke risk factors. The aim was to see if the program increased visits to doctors for heart health check-ups; researchers expected a 30% increase in visits among those using the digital tools. Who this helps: This benefits community members at risk of stroke, particularly older adults.

Plain English
Researchers developed a text message system to help prevent strokes by encouraging healthy behaviors. They reviewed over 1,500 existing health messages, tailored about 10% for stroke prevention, and created new personalized messages that are easy to read, with 98% suitable for a Grade 10 reading level or lower. This system matters because it can effectively promote lifestyle changes that reduce the risk of stroke, which is largely preventable. Who this helps: This benefits patients at risk for strokes and their families, as well as healthcare providers seeking to support stroke prevention.

Plain English
The study focused on a new drug called imetelstat, which has been approved for adults with certain blood disorders called myelodysplastic syndromes (MDS) who require frequent blood transfusions and have not benefited from other treatments. The trial found that about 39.8% of patients taking imetelstat no longer needed blood transfusions after eight weeks, compared to only 15% in the placebo group. This is important because it offers a new treatment option for patients who have not responded to current therapies, even though some patients may experience severe side effects like low blood cell counts. Who this helps: This helps patients with low- to intermediate-1 risk myelodysplastic syndromes who struggle with anemia.

Plain English
This study looked at how to effectively involve both health experts and community members in designing a digital platform called "Love Your Brain," aimed at preventing strokes. Over several months, focus groups were held with 10 health experts and 12 community participants, including 9 individuals who had experienced a stroke. The findings showed that 86% of participants attended at least five of the eight sessions, and most felt their opinions were valued in the project, which is crucial for creating tools that meet real needs. Who this helps: This benefits patients, especially those affected by stroke, and their caregivers by ensuring their voices are heard in health-related design projects.

Plain English
This research studied how to create a digital platform called "Love Your Brain" to help prevent strokes by educating the community about stroke risk factors. Researchers gathered input from 12 community members and 10 health experts through focus groups, where participants stressed the need for clear, simple language and emphasized the importance of personal stories and statistics—86% of them participated in five or more sessions. This matters because effective stroke prevention can significantly reduce health issues and save lives, making the program more engaging and informative for users. Who this helps: This benefits stroke patients, their families, and the general public looking to reduce stroke risk.

Plain English
The study focused on understanding the risk factors for Alzheimer's disease in Asian Americans and Canadians, aiming to include more diverse participants in Alzheimer's research. So far, the Asian Cohort for Alzheimer's Disease (ACAD) has successfully recruited 606 participants, with plans to enroll over 5,000 to identify both genetic and lifestyle risk factors. This research is important because it seeks to uncover how these factors affect the risk of Alzheimer's specifically in the Asian population, which has been overlooked in previous studies. Who this helps: This helps Asian patients and communities by providing insights into Alzheimer's disease.

Plain English
This study looked at whether using local vaginal estrogen treatment before a cervical exam (colposcopy) could help doctors see changes in the cervix more clearly in postmenopausal women aged 50 and older. Researchers will treat 150 women with estrogen or a placebo for two weeks before their colposcopy and check how many have a visible area (transformation zone) that is important for diagnosis. The goal is to improve detection of precancerous lesions, which is crucial to prevent cervical cancer. Who this helps: This benefits postmenopausal women at risk for cervical cancer by ensuring better diagnostic accuracy.

Plain English
The study looked at a scoring system called Swedescore, which aims to improve the process of analyzing cervical abnormalities and reduce the number of unnecessary cervical biopsies in women undergoing colposcopy in Denmark. Researchers plan to include 586 women and compare the outcomes of those evaluated with Swedescore to those assessed using traditional methods. This matters because it could lead to fewer biopsies for women who don't need them, making the process less invasive and potentially reducing anxiety and discomfort. Who this helps: This helps women undergoing cervical screening and their healthcare providers.

Plain English
This study looked at how the health of the liver and kidneys affects survival in patients with advanced non-small cell lung cancer (NSCLC) who are being treated with specific antibodies. Researchers found that while kidney function did not relate to survival rates, patients with liver problems had shorter survival times; specifically, those with baseline liver impairment lived less long compared to those without it. Understanding these effects is important because it helps doctors better predict patient outcomes and tailor treatments based on a patient's overall health. Who this helps: This helps patients with advanced lung cancer and their doctors.

Plain English
This study looked at whether stroke survivors understood the information about the medications they were prescribed to prevent future strokes. Out of 1,500 participants, only 66-75% understood their medication explanations, but those who did were nearly twice as likely to stick to their medication routine. Additionally, increased understanding was linked to feeling more in control of health risks and having fewer unmet needs, indicating that better education on medications could lead to better health outcomes. Who this helps: This helps stroke survivors and their healthcare providers.

Plain English
This study looked at how to better collect information on how much opioids patients take after surgery, using a text message and web survey approach. They found that 44% of patients reported their opioid use, and for the most common surgeries, patients used only 36% of what was prescribed, meaning a lot of unused opioids. This is important because it helps create better guidelines for how much pain medication doctors should prescribe, reducing the risk of overprescribing. Who this helps: This helps patients and doctors by ensuring safer and more accurate pain management after surgery.

Plain English
This study examined a specific knee shape known as the small medial femoral condyle (SMC) and its link to knee joint wear and tear. The researchers found that knees with an SMC were significantly smaller in certain areas—about 4% to 13% smaller in various measurements—compared to healthy knees, indicating that this unique shape increases the risk of degeneration in the knee's inner compartment. Understanding this connection is important because it can help identify individuals at higher risk for knee problems, potentially guiding prevention and treatment strategies. Who this helps: This information is useful for doctors and therapists working with patients at risk of knee degeneration.

Plain English
This study looked at how often anesthesiologists are involved in surgeries for patients who suffered traumatic injuries, using data from around 176,000 patient cases over ten years. Researchers found that about 60% of these patients received surgical anesthesia, with differing rates depending on the type of trauma center—33% surgeries occurred in level I centers, while level II centers handled 23%. Understanding these patterns is important because it can help improve care delivery in trauma settings, especially regarding the need for immediate anesthesia support for patients. Who this helps: This benefits patients who experience traumatic injuries, as well as doctors involved in trauma care.

Plain English
Researchers created and tested a new tool called the Well-Being Inventory (WBI) to better understand the lives of military veterans by examining their work, finances, health, and relationships. In studies involving over 10,000 veterans, the WBI showed that it could effectively identify veterans' needs and changes in their well-being, especially in those with mental health conditions. This matters because it helps pinpoint areas where veterans need more support, ultimately improving their quality of life. Who this helps: Veterans and the organizations that support them.

Plain English
This research focuses on the guidelines for validating bioanalytical methods, which are important for preparing pharmaceutical submissions worldwide. The International Council for Harmonization (ICH) released a draft guideline (called M10) to improve these methods, and experts recently met at a workshop to discuss it. The participants found the guideline mostly well-written but suggested changes on several topics for improvement, highlighting the need for clearer standards across different regions. Who this helps: This benefits pharmaceutical companies and researchers working to create safe and effective medications.

Plain English
The research paper discusses a workshop that brought together over 1,000 experts in pharmaceutical and regulatory fields to address current challenges in bioanalysis, which is a method used to study drugs and their effects. The workshop resulted in new recommendations intended to improve the quality and compliance of bioanalysis practices, including guidelines from the FDA and ICH related to drug testing methods and biomarker research. These findings are important because they aim to enhance the accuracy of drug testing and help ensure that new treatments are safe and effective for patients. Who this helps: This helps patients and healthcare providers by improving drug safety and effectiveness.

Plain English
The Veterans Metrics Initiative (TVMI) study looked at the health and well-being of nearly 9,600 U.S. veterans in their first three years after leaving military service. The research found that veterans' experiences vary widely and that understanding the effectiveness of different support programs is crucial for their successful transition; this includes examining which aspects of these programs are most helpful. This matters because it can lead to better support for veterans, helping them adjust to life after service. Who this helps: This research helps veterans as well as the organizations providing them with support programs.

Plain English
This research looked at whether taking both aspirin and clopidogrel (a treatment called dual antiplatelet therapy) shortly after a serious transient ischaemic attack or minor stroke can lower the chances of having another stroke or death compared to just taking aspirin alone. The experts strongly recommend starting this combined treatment within 24 hours of symptoms and continuing it for 10 to 21 days, as it can provide better protection against a recurrence than using only one medication. Who this helps: This benefits patients who have experienced a high-risk transient ischaemic attack or minor stroke.

Plain English
This study looked at how to improve dosing strategies for cancer drugs that are made from living cells, called therapeutic biologics. The researchers found that understanding how the drug behaves in the body and its effects on patients can lead to better dosing recommendations after a drug is approved. This is important because it can enhance treatment effectiveness and reduce side effects for cancer patients. Who this helps: Patients receiving cancer treatment.

Plain English
This study focused on helping rural African American cocaine users improve their safe sex practices to lower the risk of sexually transmitted infections (STIs) and HIV. Among 251 participants, those who took part in a special risk reduction program showed better skills in using condoms and negotiating safe sex compared to those in a regular control group. Both groups reported using condoms more often and reducing risky sexual behaviors, but the program participants had particularly stronger improvements. Who this helps: This helps patients, especially rural African American cocaine users, by promoting safer sexual practices.

Plain English
This study looked at the costs associated with repairing flexible ureteroscopes used in kidney stone surgeries. Over three years, 655 surgeries were performed, and 31 repairs were needed, costing a total of about $233,150, or roughly $355 per surgery. These repair costs can affect how much money the surgery center makes, so it's important to find ways to reduce damage to these instruments. Who this helps: Patients needing kidney stone treatment and the doctors who perform these procedures.

Plain English
This study looked at eight patients who developed a painful and itchy rash while exercising in Albania. They were all found to have been living near fig trees and came into contact with fig tree sap, which can cause serious skin reactions when exposed to sunlight. Understanding this connection is important because it helps prevent similar cases from happening when people are near these trees. Who this helps: This helps patients who might be exposed to fig tree sap and doctors treating skin conditions.

Plain English
This study looked at how reliable and valid the current and proposed diagnoses for pedophilia are in assessing sexual interests in children among 79 men who committed child pornography or sexual offenses against children. The research showed that the DSM-IV-TR diagnosis had a reliability score of 0.59, while the proposed DSM-5 criteria scored 0.52, indicating similar levels of reliability. Both sets of criteria effectively identified sexual interest in children based on self-reports and other tests, but the study suggests retaining the current DSM-5 guidelines as they are more familiar and established without significant improvement from the proposed changes. Who this helps: This benefits doctors and mental health professionals assessing individuals suspected of having inappropriate sexual interests.

Plain English
The study focused on the need for consistent standards in how biomarkers are measured and validated for drug development and approval. It found that prior to a 2013 guidance from the FDA, many biomarker tests lacked clear performance expectations, leading to mixed-quality data submitted for drug efficacy and safety claims. The workshop in 2015 brought together industry experts and FDA representatives to discuss these issues, improving understanding and paving the way for better practices moving forward. Who this helps: This benefits pharmaceutical companies and regulatory agencies working with biomarkers in drug development.

Plain English
The 2013 FDA guidance on bioanalytical method validation was revised to include new expectations for analyzing biomarker data, which is important for measuring the effectiveness of treatments. A workshop in December 2013 brought together experts from the FDA and the pharmaceutical industry to discuss this updated guidance, focusing on key areas such as common topics, chromatography, ligand-binding assays, and the use of biomarkers. The workshop resulted in an active exchange of ideas, identifying points of agreement and areas for further consideration by the FDA, which can ultimately improve how new medical treatments are tested and approved. Who this helps: This benefits patients by leading to better and more reliable treatment evaluations.

Plain English
This study looked at how the pesticides that parents reported using in their homes related to the actual pesticide levels found in carpet dust. It involved 277 children with leukemia and 306 healthy children in California and found that homes treating for fleas or ticks had 2.3 times more permethrin (a pesticide) in the dust, while those treating for ants or cockroaches had 2.5 times more cypermethrin. Understanding these links is important because it helps assess how household pesticide use may impact children's health, especially regarding leukemia risk. Who this helps: This helps parents and healthcare providers understand potential risks associated with pesticide use in homes.

Plain English
The recent AAPS workshop focused on improving and troubleshooting tests used to measure biological substances in the body. Attendees discussed topics such as test development, validation, and how to analyze important indicators related to drug effectiveness and immune responses. Though the workshop successfully promoted deep discussions among experienced scientists, not all topics received equal attention, particularly biomarkers and alternative testing methods. Who this helps: This helps bioanalytical scientists and researchers who develop tests for drugs and therapies.

Plain English
This study examined how different levels of a drug called T-DM1 (Kadcyla) affect the outcomes for patients with HER2-positive metastatic breast cancer. It was found that patients who had higher levels of the drug in their system (measured on day 21 of treatment) experienced better overall survival and longer periods without disease progression. Specifically, those with low drug levels had survival rates similar to patients on a different treatment, suggesting that adjusting the dose of T-DM1 could help improve results for some patients. Who this helps: This helps patients with HER2-positive metastatic breast cancer who are treated with T-DM1.

Plain English
This study looked at how the levels of the drug trastuzumab in patients with advanced gastric cancer affected their survival rates. It found that patients who had the lowest levels of the drug during their first treatment cycle lived shorter lives compared to those who had higher levels. In fact, those with low trastuzumab levels did not gain any survival benefit from the drug when added to their chemotherapy. This matters because it highlights the need for better treatment plans for patients who may not respond well to current dosages. Who this helps: This helps patients with metastatic gastric cancer and their doctors in finding more effective treatment options.

Plain English
This paper discusses a type of cancer treatment called antibody-drug conjugates (ADCs), which combine a powerful drug with an antibody to target cancer cells more effectively while minimizing side effects. The authors highlight that as more ADCs are being developed, there is a need for standardized testing methods to accurately evaluate these complex treatments, making it easier to compare their effectiveness and safety. This standardization will help ensure that clinical data on these therapies is reliable and can guide better patient care. Who this helps: This helps patients and doctors by improving treatment options and safety in cancer therapy.

Plain English
This paper discusses a recent workshop where nearly 500 experts in drug testing gathered to share knowledge about new methods in bioanalysis, a field that examines biologically active substances in the body. They focused on combining two techniques, LBA and LCMS, to improve the accuracy and efficiency of these tests. The insights shared at this workshop could lead to better testing methods for drugs, which is crucial for developing effective treatments. Who this helps: This helps patients and doctors by improving drug testing accuracy.

Plain English
This research focused on how the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are working together to align their guidelines for testing drug effectiveness. During a conference, experts discussed updates on these guidelines, including revisions to the FDA's methods for validating these tests and the EMA's finalized guidelines. These efforts aim to create more consistent testing methods globally, which can improve the drug approval process. Who this helps: This benefits pharmaceutical companies and researchers developing new treatments.

Plain English
This study looked at the effectiveness of a drug called vandetanib for treating medullary thyroid cancer that cannot be surgically removed. In a trial, patients taking vandetanib experienced a significant improvement in their progression-free survival (the time they lived without the cancer worsening) compared to those on a placebo, with a marked difference: 44% of patients on vandetanib showed improvement versus only 1% on the placebo. This matters because it's the first approved treatment specifically for this type of cancer, offering hope with a clear benefit, although it does come with some serious side effects. Who this helps: This helps patients with symptomatic or advanced medullary thyroid cancer.

Plain English
Researchers and professionals from pharmaceutical companies and regulatory agencies gathered to address recent challenges in bioanalysis, which is the science of measuring chemicals in the body. They found that there is now greater agreement among different regulatory guidelines, which helps streamline bioanalysis processes. This alignment is important for ensuring that tests are consistent and reliable worldwide, improving drug development and safety. Who this helps: This benefits patients by ensuring safer and more effective medications through improved testing standards.